Study protocol for a randomized, blinded, controlled trial of ketamine for acute painful crisis of sickle cell disease

Study protocol for a randomized, blinded, controlled trial of ketamine for acute painful crisis of sickle cell disease

Abstract Background Sickle cell disease (SCD) is an inherited hematological disorder where the shape of red blood cells is altered, resulting in the destruction of red blood cells, anemia, and other complications. SCD is prevalent in the southern and eastern provinces of the Arabian peninsula. The m...

Full description

Bibliographic Details
Main Authors: Mohammed S. Alshahrani, Laila Perlas Asonto, Mohamed M. El Tahan, Amal H. Al Sulaibikh, Sukayna Z. Al Faraj, Abdullah A. Al Mulhim, Murad F. Al Abbad, Samar A. Al Nahhash, Moath N. Aldarweesh, Alaa M. Mahmoud, Nisreen Almaghraby, Mohammed A. Al Jumaan, Thamir O. Al Junaid, Faisal M. Al Hawaj, Samar AlKenany, Omaima F. ElSayed, Haitham M. Abdelwahab, Mohamed M. Moussa, Bader K. Alossaimi, Shaikah K. Alotaibi, Talal M. AlMutairi, Duaa A. AlSulaiman, Saad D. Al Shahrani, Donia Alfaraj, Waleed Alhazzani
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Trials
Subjects:
Acute painful crisis
Ketamine
Randomized control trial
Sickle cell disease
Online Access:http://link.springer.com/article/10.1186/s13063-019-3394-4

Internet

http://link.springer.com/article/10.1186/s13063-019-3394-4

Similar Items